Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2020 Filed Feb 24, 2020 21:47 UTC |
Bonvini EzioSr VP, Research & CSO
|
GrantEmployee stock option (right to buy) · Derivative | 100,000 | $11.50 Strike: $11.50 | $1,150,000.00 |
DisclosureSEC source: 0001125345-20-000027 · wf-form4_158258084014609.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:47 UTC |
Cilinski LynnVP, Controller and Treasurer
|
GrantEmployee stock option (right to buy) · Derivative | 35,000 | $11.50 Strike: $11.50 | $402,500.00 |
DisclosureSEC source: 0001125345-20-000026 · wf-form4_158258081922732.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:46 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
GrantEmployee stock option (right to buy) · Derivative | 100,000 | $11.50 Strike: $11.50 | $1,150,000.00 |
DisclosureSEC source: 0001125345-20-000024 · wf-form4_158258077603500.xml · derivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:46 UTC |
Karrels JamesSVP, CFO and Secretary
|
GrantEmployee stock option (right to buy) · Derivative | 90,000 | $11.50 Strike: $11.50 | $1,035,000.00 |
DisclosureSEC source: 0001125345-20-000025 · wf-form4_158258079911418.xml · derivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:45 UTC |
Koenig ScottDirector · President and CEO
|
GrantEmployee stock option (right to buy) · Derivative | 290,000 | $11.50 Strike: $11.50 | $3,335,000.00 |
DisclosureSEC source: 0001125345-20-000022 · wf-form4_158258073276662.xml · derivative · entry 1 Koenig Scott · CIK 0001587514 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,000 Underlying: Common Stock · 290,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:46 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
GrantEmployee stock option (right to buy) · Derivative | 90,000 | $11.50 Strike: $11.50 | $1,035,000.00 |
DisclosureSEC source: 0001125345-20-000023 · wf-form4_158258075393547.xml · derivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:45 UTC |
Peters Jeffrey StuartGeneral Counsel
|
GrantEmployee stock option (right to buy) · Derivative | 87,000 | $11.50 Strike: $11.50 | $1,000,500.00 |
DisclosureSEC source: 0001125345-20-000021 · wf-form4_158258071062899.xml · derivative · entry 1 Peters Jeffrey Stuart · CIK 0001706903 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,000 Underlying: Common Stock · 87,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:45 UTC |
Spitznagel ThomasSr VP, BPD & Manufacturing
|
GrantEmployee stock option (right to buy) · Derivative | 87,000 | $11.50 Strike: $11.50 | $1,000,500.00 |
DisclosureSEC source: 0001125345-20-000020 · wf-form4_158258068883545.xml · derivative · entry 1 Spitznagel Thomas · CIK 0001675464 · Sr VP, BPD & Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,000 Underlying: Common Stock · 87,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:41 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 623 | $0.94 Strike: $0.94 | $585.62 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · derivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 623 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:41 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 623 | $10.00 | $6,230.00 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:41 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 623 | $0.94 | $585.62 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:41 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 30 | $0.94 Strike: $0.94 | $28.20 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · derivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,623 Underlying: Common Stock · 30 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:41 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 30 | $10.00 | $300.00 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:41 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 30 | $0.94 | $28.20 |
DisclosureSEC source: 0001125345-20-000009 · wf-form4_158102526689957.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 21:45 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,180 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000005 · wf-form4_158050709025869.xml · derivative · entry 4 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,473 Underlying: Common Stock · 5,180 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 21:45 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,320 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000005 · wf-form4_158050709025869.xml · derivative · entry 3 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,320 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 21:45 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionCommon Stock | 5,180 | $0.94 | $4,869.20 |
DisclosureSEC source: 0001125345-20-000005 · wf-form4_158050709025869.xml · nonDerivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 21:45 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionCommon Stock | 7,320 | $0.94 | $6,880.80 |
DisclosureSEC source: 0001125345-20-000005 · wf-form4_158050709025869.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse. Read SEC document |
| September 27, 2019 Filed Oct 3, 2019 20:33 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,662 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000100 · wf-form4_157013477244564.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,662 shares Expires 2020-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| September 27, 2019 Filed Oct 3, 2019 20:33 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 1,662 | $0.94 | $1,562.28 |
DisclosureSEC source: 0001125345-19-000100 · wf-form4_157013477244564.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2019 Filed May 22, 2019 20:21 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · derivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,662 Underlying: Common Stock · 1,000 shares Expires 2020-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2019 Filed May 22, 2019 20:21 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 1,000 | $19.03 | $19,026.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2019. F3 · price: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $19.00 to $19.026. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 22, 2019 Filed May 22, 2019 20:21 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 1,000 | $0.94 | $940.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:21 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · derivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,653 Underlying: Common Stock · 3,000 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:21 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 3,000 | $18.38 | $55,131.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2019. F2 · price: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $18.25 to $18.50. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:21 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-19-000083 · wf-form4_155855647815200.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:49 UTC |
Costa Paulo FDirector
|
GrantStock Option (right to buy) · Derivative | 7,357 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000076 · wf-form4_155838894365490.xml · derivative · entry 2 Costa Paulo F · CIK 0001465928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,357 Underlying: Common Stock · 7,357 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. F2 · derivative.underlying_shares: At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:49 UTC |
Costa Paulo FDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000076 · wf-form4_155838894365490.xml · derivative · entry 1 Costa Paulo F · CIK 0001465928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:48 UTC |
STUMP DAVID CDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000074 · wf-form4_155838889000225.xml · derivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:50 UTC |
SIEGEL JAY PHILIPDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000079 · wf-form4_155838902030594.xml · derivative · entry 1 SIEGEL JAY PHILIP · CIK 0001722857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:48 UTC |
HURWITZ EDWARDDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000075 · wf-form4_155838891757750.xml · derivative · entry 1 HURWITZ EDWARD · CIK 0001211840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:50 UTC |
Ferrante Karen JeanDirector
|
GrantStock Option (right to buy) · Derivative | 4,616 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000078 · wf-form4_155838899552570.xml · derivative · entry 2 Ferrante Karen Jean · CIK 0001598502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,616 Underlying: Common Stock · 4,616 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. F2 · derivative.underlying_shares: At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:50 UTC |
Ferrante Karen JeanDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000078 · wf-form4_155838899552570.xml · derivative · entry 1 Ferrante Karen Jean · CIK 0001598502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:49 UTC |
Galbraith KennethDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000077 · wf-form4_155838896990746.xml · derivative · entry 1 Galbraith Kenneth · CIK 0001567045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:47 UTC |
Jackson Scott ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000073 · wf-form4_155838886506188.xml · derivative · entry 1 Jackson Scott Thomas · CIK 0001566617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:47 UTC |
Fust Matthew KDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001125345-19-000072 · wf-form4_155838884018358.xml · derivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:36 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,497 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000050 · wf-form4_155294139184437.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,497 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:36 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 2,497 | $0.94 | $2,347.18 |
DisclosureSEC source: 0001125345-19-000050 · wf-form4_155294139184437.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:03 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
GrantEmployee stock option (right to buy) · Derivative | 85,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000034 · wf-form4_155112859605813.xml · derivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:03 UTC |
Spitznagel ThomasSr VP, BPD & Manufacturing
|
GrantEmployee stock option (right to buy) · Derivative | 70,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000033 · wf-form4_155112857112121.xml · derivative · entry 1 Spitznagel Thomas · CIK 0001675464 · Sr VP, BPD & Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:02 UTC |
Karrels JamesSVP, CFO and Secretary
|
GrantEmployee stock option (right to buy) · Derivative | 85,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000032 · wf-form4_155112854542763.xml · derivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:02 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
GrantEmployee stock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000031 · wf-form4_155112852052571.xml · derivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:01 UTC |
Cilinski LynnVP, Controller and Treasurer
|
GrantEmployee stock option (right to buy) · Derivative | 35,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000030 · wf-form4_155112849544101.xml · derivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:01 UTC |
Bonvini EzioSr VP, Research & CSO
|
GrantEmployee stock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000029 · wf-form4_155112847071551.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:01 UTC |
Peters Jeffrey StuartGeneral Counsel
|
GrantEmployee stock option (right to buy) · Derivative | 70,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000028 · wf-form4_155112844594088.xml · derivative · entry 1 Peters Jeffrey Stuart · CIK 0001706903 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:00 UTC |
Koenig ScottDirector · President and CEO
|
GrantEmployee stock option (right to buy) · Derivative | 260,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000027 · wf-form4_155112842141714.xml · derivative · entry 1 Koenig Scott · CIK 0001587514 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:41 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,924 | $0.00 Strike: $20.15 | $0.00 |
DisclosureSEC source: 0001125345-19-000018 · wf-form4_154966566940123.xml · derivative · entry 3 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,924 shares Expires 2024-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:41 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 6,924 | $29.38 | $203,427.12 |
DisclosureSEC source: 0001125345-19-000018 · wf-form4_154966566940123.xml · nonDerivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2018. F2 · price: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $29.23 to $29.73. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:41 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 6,924 | $20.15 | $139,518.60 |
DisclosureSEC source: 0001125345-19-000018 · wf-form4_154966566940123.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:40 UTC |
Peters Jeffrey StuartGeneral Counsel
|
SaleCommon Stock | 68 | $30.00 | $2,040.00 |
DisclosureSEC source: 0001125345-19-000017 · wf-form4_154966563401465.xml · nonDerivative · entry 1 Peters Jeffrey Stuart · CIK 0001706903 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.